V. Yu. Reshetnyak

V. Yu. Reshetnyak

Auto-generated profile, based on publicly available information

V. Yu. Reshetnyak

Sechenov First Moscow State Medical University

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
ONO. I. Nikulina
O. I. Nikulina
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
ABA. V. Belyatskaya
A. V. Belyatskaya
YKYu. Ya. Kharitonov
Yu. Ya. Kharitonov
VPV. A. Popkov
V. A. Popkov
VRV. Yu. Reshetnyak
V. Yu. Reshetnyak

26 November 2020 in Drug development & registration
Verified
Journal Article
Open access
PDF file
DKD. A. Kozin
D. A. Kozin
ZSZoya Shprakh
Zoya Shprakh
VRV. Yu. Reshetnyak
V. Yu. Reshetnyak
ONOlga Vladimirovna Nesterova
Olga Vladimirovna Nesterova
IAI. N. Avertseva
I. N. Avertseva
ВРВ. Ю. Решетняк
В. Ю. Решетняк
Introduction. Currently, more than 600 thousand people a year are affected by malignant tumors on the territory of the Russian Federation. Despite the large selection of antitumor drugs and the variety of mechanisms of their action, the effectiveness of existing drugs continues to be insufficient. The main disadvantages of most antitumor drugs are the emergence of tolerance to them of tumor cells, a limited range of action and high toxicity. In this regard, the creation of effective original domestic antitumor drugs still remains relevant. Among the numerous natural and synthetic heterocyclic compounds that exhibit antitumor activity, indolo[2,3-a]carbazole derivatives that can initiate various pathways of tumor cell death are of increasing interest. The main targets for their action are topoisomerases and protein kinases, which play an important role in the processes of replication, transcription, repair or recombination of deoxyribonucleic acid (DNA). Due to this, in addition to antitumor activity, this group of compounds shows antibacterial, аntiprotozoal and immunomodulatory activity, which makes them a very promising class of candidates for the creation of new drugs.Text. The purpose of this review is to discuss instrumental methods for qualitative and quantitative analysis of indolo[2,3-a]carbazole derivatives used in the world's leading pharmacopoeias. These methods can be used both in pharmacokinetic studies, and in the standardization of these compounds, in the form of pharmaceutical substances, or as part of drug forms.Conclusion. To further introduce a new group of antitumor drugs based on indole[2,3-a]carbazole derivatives into medical practice, a deep and thorough study of their physical and chemical properties is necessary. Justification and development of analysis methods allow us to develop methods applicable to pharmacokinetic studies, as well as to create regulatory documents for quality control and standardization of indolo[2,3-a] carbazole derivatives as pharmaceutical substances. A study of the literature that describes methods for analyzing indolo[2,3-a]carbazole derivatives indicates that spectrometric (infrared and ultraviolet spectrometry) and chromatographic (thin-layer chromatography and high-performance liquid chromatography) methods are most often used to determine the authenticity and quantitative analysis of these compounds.

1 March 2004 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
AEA. V. Eremina
A. V. Eremina
VRV. Yu. Reshetnyak
V. Yu. Reshetnyak
MVM. O. Vezirishvili
M. O. Vezirishvili

1 November 2009 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
RKR. U. Khabriev
R. U. Khabriev
VPV. A. Popkov
V. A. Popkov
VRV. Yu. Reshetnyak
V. Yu. Reshetnyak
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
ALA. S. Lapshova
A. S. Lapshova

1 February 2011 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
ALA. S. Lapshova
A. S. Lapshova
RKR. U. Khabriev
R. U. Khabriev
VPV. A. Popkov
V. A. Popkov
VRV. Yu. Reshetnyak
V. Yu. Reshetnyak
OKO. I. Krasnyuk
O. I. Krasnyuk

30 January 2023 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
KDKozin D.A.
Kozin D.A.
SZShprakh Z.S.
Shprakh Z.S.
BABudko A.P.
Budko A.P.
PRPugacheva R.B.
Pugacheva R.B.
ELEktova L.V.
Ektova L.V.
ONOlga Vladimirovna Nesterova
Olga Vladimirovna Nesterova
The N.N. Blokhin Oncology Research Center synthesized indolo[2,3-a]carbazole N-glycoside, which received the laboratory cipher LСS-1269, which showed a pronounced antitumor effect during research.. During the study of LСS-1269 by HPLC, the presence of two impurities was revealed, called LСS-1269-X and LСS-1269-Y (impurities X and Y). The electronic absorption spectrum (EAS) of the impurity peak X was similar to the EAS of the indolo[2,3-a]carbazole N-glycoside obtained and described earlier under the laboratory cipher LCS-1208, and the EAS of the impurity was the spectrum of LCS–1269, which indicates that the impurities belong to indolo[2,3-a]carbazoles. In this regard, it is suggested about the structure of these impurities: impurity X is a xyloside of aglycone similar in structure to aglycone LCS-1208, which can be formed as a by-product at one of the last stages of the synthesis of LCS-1269, and impurity Y has the structure of triacetyl ester LCS-1269, which is a precursor of LCS-1269 in the synthesis process. The aim of the work was to identify impurities in the substance LHS-1C69, to confirm their structures and belonging to derivatives of indolo[2,3-a]carbazole. The identification of impurities in the substance LCS-1269 was carried out using the HPLC-MSMS method. For this purpose, X and Y impurities having the assumed structures were obtained by directed counter synthesis, which were used as reference samples. Comparison of peak retention times on extracted ion chromatograms (XIC) and MSMS spectra of impurities with XIC and MSMS spectra of samples of comparison of the alleged impurities confirmed their structure. As a result of the work carried out, the structures of impurities X and Y were identified and the affiliation of these impurities to derivatives of indolo[2,3-a]carbazole was confirmed.